🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Status
Active Not Recruiting
Location
Syneos Health Clinical Research Services, LLC
Start Date
2025-11-17
Trial ID
NCT07350577
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
Randomized, placebo-controlled, double-blind, parallel design, Phase 3 stud...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2009-09
Trial ID
NCT01037244
This is a randomized, double-blind, active drug- and placebo-controlled, do...
Status
Recruiting
Location
The Third Xiangya Hospital of Central South University
Start Date
2026-03-30
Trial ID
NCT07519109
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
This is a phase one study to assess the safety of daily dosing of Lactobaci...
Status
Completed
Location
Community of Santa Clara
Start Date
2010-02
Trial ID
NCT00774163
Treatments Being Tested
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
This is a multicenter, randomized, double-blind, placebo-controlled, dose-E...
Status
Completed
Location
Allife Medicine （Beijing） Limitied
Start Date
2023-08-24
Trial ID
NCT05993884
This randomized, double-blind, placebo-controlled, single ascending dose st...
Status
Completed
Location
Changi General Hospital; Clinical Trial & Research unit
Start Date
2013-12
Trial ID
NCT02015715